Immunology, Microbiology, Internal medicine, Bifidobacterium longum and Staphylococcus aureus are his primary areas of study. Immunology is closely attributed to Cytotoxic T cell in his work. His Cytotoxic T cell course of study focuses on Pathology and Peripheral T-cell lymphoma.
His Microbiology study combines topics in areas such as Actinomycetaceae, Lactoferrin and Biofilm. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology and Oncology. His Bifidobacterium longum study incorporates themes from Probiotic, Bacteria and Fermentation.
His primary areas of investigation include Immunology, Pathology, Dermatology, Internal medicine and Virology. The Immunology study which covers Cytotoxic T cell that intersects with Antigen. Keiji Iwatsuki does research in Pathology, focusing on Lymphoma specifically.
His biological study spans a wide range of topics, including Gastroenterology and Endocrinology. Keiji Iwatsuki works mostly in the field of Antibody, limiting it down to topics relating to Pemphigus vulgaris and, in certain cases, Pemphigus foliaceus and Pemphigus. The various areas that Keiji Iwatsuki examines in his Lymphoproliferative disorders study include Chronic active EBV infection and Hydroa vacciniforme.
Immunology, Dermatology, Pathology, Internal medicine and Cancer research are his primary areas of study. His Antibody, Autoantibody, Pemphigus foliaceus, Hydroa vacciniforme and Lymphoproliferative disorders investigations are all subjects of Immunology research. The study incorporates disciplines such as Adalimumab, Antibiotics, Arteritis and MEDLINE in addition to Dermatology.
His work in the fields of Pathology, such as Lymphoma, intersects with other areas such as In patient. His work deals with themes such as CD3 and CD8, which intersect with Lymphoma. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology and Oncology.
His primary scientific interests are in Immunology, Internal medicine, Pathology, Gastroenterology and Dermatology. All of his Immunology and Virus, Epstein–Barr virus, Nivolumab, Antibody and Serum amyloid A investigations are sub-components of the entire Immunology study. As a part of the same scientific study, Keiji Iwatsuki usually deals with the Internal medicine, concentrating on Oncology and frequently concerns with Apocrine, Chemotherapy, Chemotherapy regimen, Taxane and Targeted therapy.
His Pathology research is multidisciplinary, incorporating elements of Mutation, Melanoma and Pityriasis rubra pilaris. His study looks at the relationship between Gastroenterology and fields such as Cutaneous T-cell lymphoma, as well as how they intersect with chemical problems. His research integrates issues of Antibacterial susceptibility, Antibiotics, Antibiotic resistance and Staphylococcus epidermidis in his study of Dermatology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.
Elise A. Olsen;Sean Whittaker;Youn H. Kim;Madeleine Duvic.
Journal of Clinical Oncology (2011)
Defining early mycosis fungoides.
Nicola Pimpinelli;Elise A. Olsen;Marco Santucci;Eric Vonderheid.
Journal of The American Academy of Dermatology (2005)
A randomized double-blind trial of intravenous immunoglobulin for pemphigus
Masayuki Amagai;Shigaku Ikeda;Hiroshi Shimizu;Hajime Iizuka.
Journal of The American Academy of Dermatology (2009)
Twenty-five years of research on bovine lactoferrin applications.
Mamoru Tomita;Hiroyuki Wakabayashi;Kouichirou Shin;Koji Yamauchi.
Biochimie (2009)
Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type
R. Suzuki;J. Suzumiya;M. Yamaguchi;S. Nakamura.
Annals of Oncology (2010)
Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity.
Shizuki Kondo;Jin-zhong Xiao;Takumi Satoh;Toshitaka Odamaki.
Bioscience, Biotechnology, and Biochemistry (2010)
The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury.
Yuping Lai;Dongqing Li;Changwei Li;Beda Muehleisen.
Immunity (2012)
Cathelicidin Antimicrobial Peptide LL-37 in Psoriasis Enables Keratinocyte Reactivity against TLR9 Ligands
Shin Morizane;Kenshi Yamasaki;Kenshi Yamasaki;Beda Mühleisen;Paul F. Kotol.
Journal of Investigative Dermatology (2012)
Staphylococcal cutaneous infections: invasion, evasion and aggression.
Keiji Iwatsuki;Osamu Yamasaki;Shin Morizane;Takashi Oono.
Journal of Dermatological Science (2006)
Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
Keiji Iwatsuki;Masataka Satoh;Takenobu Yamamoto;Takashi Oono.
Archives of Dermatology (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Hamamatsu University
Nagoya University
Osaka Metropolitan University
Okayama University
Tohoku University
Kurume University
Keio University
Nagoya University
International University of Health and Welfare
Tohoku University
Northeastern University
Chinese Academy of Sciences
The University of Texas Southwestern Medical Center
James Cook University
Washington University in St. Louis
University of Washington
University of Potsdam
University of Concepción
University of Barcelona
Auburn University
Scripps Research Institute
University of Amsterdam
Florida State University
Democritus University of Thrace
Cancer Prevention Institute of California
Wilfrid Laurier University